YU39545B - Process for the manufacture of 2-hydroxymethyl-3-hydroxy-6(1-hydroxy-2-tert.-butylaminoethyl)pyridine - Google Patents

Process for the manufacture of 2-hydroxymethyl-3-hydroxy-6(1-hydroxy-2-tert.-butylaminoethyl)pyridine

Info

Publication number
YU39545B
YU39545B YU2165/76A YU216576A YU39545B YU 39545 B YU39545 B YU 39545B YU 2165/76 A YU2165/76 A YU 2165/76A YU 216576 A YU216576 A YU 216576A YU 39545 B YU39545 B YU 39545B
Authority
YU
Yugoslavia
Prior art keywords
hydroxy
butylaminoethyl
hydroxymethyl
pyridine
tert
Prior art date
Application number
YU2165/76A
Other languages
English (en)
Other versions
YU216576A (en
Inventor
D R Carroll
R J Tretter
S B Moore
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of YU216576A publication Critical patent/YU216576A/xx
Publication of YU39545B publication Critical patent/YU39545B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/65One oxygen atom attached in position 3 or 5

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
YU2165/76A 1975-10-03 1976-09-03 Process for the manufacture of 2-hydroxymethyl-3-hydroxy-6(1-hydroxy-2-tert.-butylaminoethyl)pyridine YU39545B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/619,302 US4011231A (en) 1975-10-03 1975-10-03 2-Phenyl-6-(1-hydroxy-2-t-butylaminoethyl)-4H-pyrido[3,2-d]-1,3-dioxin maleate and its use as an intermediate

Publications (2)

Publication Number Publication Date
YU216576A YU216576A (en) 1982-06-30
YU39545B true YU39545B (en) 1984-12-31

Family

ID=24481329

Family Applications (1)

Application Number Title Priority Date Filing Date
YU2165/76A YU39545B (en) 1975-10-03 1976-09-03 Process for the manufacture of 2-hydroxymethyl-3-hydroxy-6(1-hydroxy-2-tert.-butylaminoethyl)pyridine

Country Status (30)

Country Link
US (1) US4011231A (fi)
JP (1) JPS5246081A (fi)
AR (1) AR213180A1 (fi)
AT (1) AT353789B (fi)
BE (1) BE846471A (fi)
BG (1) BG27544A3 (fi)
CA (1) CA1059518A (fi)
CH (1) CH616424A5 (fi)
CS (2) CS205042B2 (fi)
DD (2) DD133672A5 (fi)
DE (1) DE2640123C3 (fi)
DK (1) DK147049C (fi)
ES (2) ES451746A1 (fi)
FI (1) FI64354C (fi)
FR (1) FR2326191A1 (fi)
GB (1) GB1510075A (fi)
GR (1) GR61628B (fi)
HU (2) HU177493B (fi)
IE (1) IE43503B1 (fi)
LU (1) LU75898A1 (fi)
NL (1) NL164274C (fi)
NO (1) NO147027C (fi)
PH (1) PH14511A (fi)
PL (1) PL106863B1 (fi)
PT (1) PT65619B (fi)
RO (1) RO69886A (fi)
SE (2) SE428127B (fi)
SU (2) SU673168A3 (fi)
YU (1) YU39545B (fi)
ZA (1) ZA765253B (fi)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4477671A (en) * 1981-02-09 1984-10-16 Pfizer Inc. 3-Acetoxy or benzyloxy-2-acetoxymethyl-6-[1-acetoxy-2-(N-tert-butylacetamido)ethyl]pyridine intermediates
US4632992A (en) * 1981-02-09 1986-12-30 Pfizer Inc. Intermediates for preparing pirbuterol and analogs
US5395939A (en) * 1993-11-30 1995-03-07 North Carolina State University Method of making asymmetric de ring intermediates for the synthesis of camptothecin and camptothecin analogs

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3250778A (en) * 1962-11-29 1966-05-10 Hoffmann La Roche Intermediates for and synthesis of vitamin b and related compounds
US3700681A (en) * 1971-02-16 1972-10-24 Pfizer 2-hydroxymethyl-3-hydroxy-6-(1-hydroxy-2-aminoethyl)pyridines

Also Published As

Publication number Publication date
FI64354B (fi) 1983-07-29
US4011231A (en) 1977-03-08
NL7610683A (nl) 1977-04-05
NL164274C (nl) 1980-12-15
CA1059518A (en) 1979-07-31
DK147049B (da) 1984-03-26
NO763307L (fi) 1977-04-05
AT353789B (de) 1979-12-10
DE2640123B2 (de) 1980-01-31
FI64354C (fi) 1983-11-10
IE43503B1 (en) 1981-03-11
IE43503L (en) 1977-04-03
FR2326191B1 (fi) 1978-11-17
SE7609497L (sv) 1977-04-04
PH14511A (en) 1981-08-24
DD133672A5 (de) 1979-01-17
ZA765253B (en) 1977-08-31
RO69886A (ro) 1981-09-24
PT65619A (en) 1976-10-01
HU177493B (en) 1981-10-28
PL106863B1 (pl) 1980-01-31
SU673168A3 (ru) 1979-07-05
HU172998B (hu) 1979-01-28
AU1788376A (en) 1978-03-16
SE428127B (sv) 1983-06-06
FR2326191A1 (fr) 1977-04-29
NL164274B (nl) 1980-07-15
DD129325A5 (de) 1978-01-11
CH616424A5 (fi) 1980-03-31
CS205042B2 (en) 1981-04-30
DK434176A (da) 1977-04-04
ATA692376A (de) 1979-05-15
LU75898A1 (fi) 1977-05-11
DE2640123A1 (de) 1977-04-07
BE846471A (fr) 1977-03-23
SE8003311L (sv) 1980-04-30
GR61628B (en) 1978-12-04
NO147027C (no) 1983-01-19
YU216576A (en) 1982-06-30
DK147049C (da) 1984-10-01
NO147027B (no) 1982-10-11
CS205041B2 (en) 1981-04-30
ES457257A1 (es) 1978-02-01
SU725562A3 (ru) 1980-03-30
ES451746A1 (es) 1977-08-16
AR213180A1 (es) 1978-12-29
GB1510075A (en) 1978-05-10
FI762693A (fi) 1977-04-04
JPS5519210B2 (fi) 1980-05-24
SE437159B (sv) 1985-02-11
BG27544A3 (en) 1979-11-12
JPS5246081A (en) 1977-04-12
DE2640123C3 (de) 1980-09-25
PT65619B (en) 1978-04-05

Similar Documents

Publication Publication Date Title
GB1547802A (en) Process for the preparation of poly-phenyleneterephthalamide
YU39479B (en) Process for the manufacture of thieno-pyridine derivatives
PT65946B (en) Process for the manufacture of glucosamine derivatives
GB1542442A (en) Process for the manufacture of nucleosides
PT65486A (en) Process for the preparation of carbonil-substituted 1-sulfonylbenzimidazoles
GB1517423A (en) Process for the preparation of diaryl-carbonates
HU171396B (hu) Sposob poluchenija proizvodnykh rifamicina
PT64878A (en) Process for the preparation of new indolylalkylpiperidines
PT65255B (en) Process for the preparation of 11-desoxy-16-aryloxy-w-tetranorprostaglandins
HU171395B (hu) Sposob poluchenija proizvodnykh rifamicina
GB1519543A (en) Process for the producktion of formaldehyde
CH608786A5 (en) Process for the preparation of acetoacetylarylamides
GB1534077A (en) Process for the preparation of 5-acetoacetylamino-benzimidazolone
JPS5233653A (en) Process for manufacture of nnalicyclic crbamate
GB1520681A (en) Process for the production of phoroglucinol
YU39545B (en) Process for the manufacture of 2-hydroxymethyl-3-hydroxy-6(1-hydroxy-2-tert.-butylaminoethyl)pyridine
GB1520330A (en) Process for the preparation of phospholene-1-oxides or su-lphides
GB1551120A (en) Process for the manufacture of 16-20-keto-steroids
EG12648A (en) Process for the production of 9-hydroxydibenzo(b,cl)pyrans and intermediates thereof
YU39478B (en) Process for the manufacture of azomethine derivatives
JPS5278850A (en) Process for manufacture of 44chloroo22 butylmmchlorocarbanilate
GB1521558A (en) Process for the production of o-derivatives of rho-isopropenyl phenol
GB1548670A (en) Pricess for the production of 2-amino-3-hydroxypyridines
ZA763221B (en) Process for the preparation of 3-bromobenzalidehyde
PT65821A (en) Process for the preparation of novel d-homosteroids